[go: up one dir, main page]

SE455201B - Diagnostic technique for e.g. cell detection - Google Patents

Diagnostic technique for e.g. cell detection

Info

Publication number
SE455201B
SE455201B SE8200479A SE8200479A SE455201B SE 455201 B SE455201 B SE 455201B SE 8200479 A SE8200479 A SE 8200479A SE 8200479 A SE8200479 A SE 8200479A SE 455201 B SE455201 B SE 455201B
Authority
SE
Sweden
Prior art keywords
dna
rna
specific
marker
fragment
Prior art date
Application number
SE8200479A
Other languages
Swedish (sv)
Other versions
SE8200479L (en
Inventor
H Wolf-Watz
Original Assignee
Forsvarets Forsknings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forsvarets Forsknings filed Critical Forsvarets Forsknings
Priority to SE8200479A priority Critical patent/SE455201B/en
Publication of SE8200479L publication Critical patent/SE8200479L/en
Publication of SE455201B publication Critical patent/SE455201B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Diagnostic procedure uses a DNA hybridisation technique e.g. for specific labelling of tissues, cells, microorganisms or viruses. Species specific fragments of DNA or RNA having a marker are hybridised with a corresponding fragment of the desired material. The marker can be detected by chemilumin-escence. Used as a diagnostic procedure of cells etc. using DNA or 10A. (Provisional Basic previously advised in Week 83-37)

Description

455 201 eukaryot ursprung. 455 201 eukaryotic origin.

Speciellt lämpliga som markörer är luminol och isoluminol, vilka har for- meln NHZ O O NH 25-ZZ IE IE I NH l o o luminol isoluminol där NH2-gruppen avses att kopplas till olika NH2-grupper på DNA- alterna- tivt RNA-molekylen med hjälp av exempelvis glutaraldehyd eller bensokinon.Particularly suitable as markers are luminol and isoluminol, which have the formula NHZ OO NH 25-ZZ IE IE I NH loo luminol isoluminol where the NH2 group is intended to be linked to different NH2 groups on the DNA-alternative RNA molecule by means of of, for example, glutaraldehyde or benzoquinone.

Efter reaktionen med frisläppt DNA eller RNA från det okända provet och separation av hybridiserad och icke hybridiserad DNA resp RNA, t ex genom filtrering, kan graden av hybridisering uppmätas genom uppmätning av lumi- niscensstyrkan. Då således det märkta DNA- eller RNA-fragmentet är speci- fikt för t ex en given vävnad, cell, mikroorganism eller virus, kan förfa- randet enligt uppfinningen användas för såväl kvalitativ som kvantitativ påvisning av denna vävnad, cell etc.After the reaction with released DNA or RNA from the unknown sample and separation of hybridized and non-hybridized DNA or RNA, for example by filtration, the degree of hybridization can be measured by measuring the luminescence strength. Thus, since the labeled DNA or RNA fragment is specific for, for example, a given tissue, cell, microorganism or virus, the method of the invention can be used for both qualitative and quantitative detection of this tissue, cell, etc.

Genom förfarandet enligt uppfinningen undvikes således de problem, som märkning med radioaktiva isotoper medför.The process according to the invention thus avoids the problems which labeling with radioactive isotopes entails.

Inmärkningsproceduren i förfarandet enligt uppfinningen kan emellertid i vissa fall påverka hybridiseringsreaktionen negativt genom att främmande molekyler införs i DNA-strukturen respektive RNA-strukturen. Denna olä- genhet kan emellertid undanröjas, om den artspecifika DNA-sekvensen respektive RNA-sekvensen skyddas under inmärkningsproceduren genom hybri- disering med den homologa sekvensen, varvid markören binds till omgivande, icke-specifika delar av DNA- eller RNA-molekylen.However, the labeling procedure of the process of the invention may in some cases adversely affect the hybridization reaction by introducing foreign molecules into the DNA structure and the RNA structure, respectively. However, this disadvantage can be eliminated if the species-specific DNA sequence and the RNA sequence, respectively, are protected during the labeling procedure by hybridizing with the homologous sequence, thereby binding the marker to surrounding, non-specific parts of the DNA or RNA molecule.

Uppfinningen kommer nu att närmare åskådliggöras i följande exempel. j! ~.~:nf-'í5dv.\' fw- _ ~:- -..- I-'n-:i 12: 455 201 Exempel 1 Inmärkning av DNA med isoluminol Specifikt DNA (1 pg) resuspenderas i 100 pl 0,1 M fosfatbuffert (pH 6,8), och lösningen upphettas till 95°C i 5 min. Efter avsvalning till rumstem- peratur tillsättes glutaraldehyd (1,25 % slutkonc). Efter 18 tim i rums- temperatur separeras ej DNA-bunden glutaraldehyd genom gelfiltrering, Sephadex G-50 (pasteurpipett) jämviktad med 0,1 M NaCl. Droppvisa frak- tioner (50 pl) tas ut, och fraktion 8-15 hälls samman. Till de sammanför- da fraktionerna 8-15 sätts 25 pg isoluminol och 20 pl av 1 M karbonat- bikarbonat-buffert (pH 9,5). Efter 24 tim i 4°C tillsätts lysin 0,2 M.The invention will now be further illustrated in the following examples. j! ~. ~: nf-'í5dv. \ 'fw- _ ~: - -..- I-'n-: i 12: 455 201 Example 1 Labeling of DNA with isoluminol Specific DNA (1 pg) is resuspended in 100 μl 0 , 1 M phosphate buffer (pH 6.8), and the solution is heated to 95 ° C for 5 min. After cooling to room temperature, glutaraldehyde (1.25% final conc) is added. After 18 hours at room temperature, DNA-bound glutaraldehyde is not separated by gel filtration, Sephadex G-50 (pasteur pipette) equilibrated with 0.1 M NaCl. Drop fractions (50 μl) are taken out, and fractions 8-15 are combined. To the pooled fractions 8-15 are added 25 pg of isoluminol and 20 μl of 1 M carbonate-bicarbonate buffer (pH 9.5). After 24 hours at 4 ° C, 0.2 M lysine is added.

DNA-glutaraldehyd-isoluminol-komplexet skiljs ifrån andra komponenter genom ytterligare en gelfiltrering (som ovan). Fraktionerna 8-15 innehål- ler den isoluminolinmärkta DNA-proben, och detta material används sedan direkt vid hybridisering.The DNA-glutaraldehyde-isoluminol complex is separated from other components by an additional gel filtration (as above). Fractions 8-15 contain the isoluminoline-labeled DNA probe, and this material is then used directly in hybridization.

Hybridisering på nitrocellulosafilter Nitrocellulosafilter fuktas i destillerat vatten och placeras på ett dubbellager torrt filterpapper (Whatman no 3). Bakterieprovet läggs på som en känd volym av en bakteriesuspension i PBS-buffert (fosfatbuffrad natriumklorid) eller ett direktprov från patient, t ex avföringsprov (frågeställning: närvaro av enterotoxinproducerande E. coli).Hybridization on nitrocellulose filters Nitrocellulose filters are moistened in distilled water and placed on a double layer of dry filter paper (Whatman no 3). The bacterial sample is applied as a known volume of a bacterial suspension in PBS buffer (phosphate buffered sodium chloride) or a direct sample from a patient, eg faecal sample (question: presence of enterotoxin-producing E. coli).

När proven torkat in, placeras varje filter på ett dubbellager filterpap-1 per, som mättats med 0,5 M Na0H, och inkuberas 10 min i rumstemperatur.Once the samples have dried, each filter is placed on a double layer of filter paper, saturated with 0.5 M NaOH, and incubated for 10 minutes at room temperature.

Därefter överförs filtren med 1-minuters intervaller till tre successiva neutraliseringar på filterpapper mättade med 1 M Tris (trishydroximetyl- aminometan), pH 7. Slutligen placeras filtren 10 min på filterpapper, som mättas med 1 M Tris, pH 7 och 1,5 M NaCl och lufttorkas därefter. Filtren bakas 2 tim i 80°C under vakuum. Under 15 min prehybridiseras filtren i en lösning bestående av 50 % formamid, 0,75 M NaCl, 0,075 M Na-citrat, 0,1 % SDS (natriumdodecylsulfat), 1 mM EDTA (etylendiamintetraacetat), 0,02 % Ficoll (polymer) (molvikt = 400 000), 0,02 % polyvinylpyrrolidon (molvikt = 360 000) samt 0,02 % bovint serumalbumin. Prehybridiseringen sker i 42°c.The filters are then transferred at 1-minute intervals to three successive neutralizations on filter paper saturated with 1 M Tris (trishydroxymethylaminomethane), pH 7. Finally, the filters are placed for 10 minutes on filter paper, which is saturated with 1 M Tris, pH 7 and 1.5 M NaCl and then air dried. The filters are baked for 2 hours at 80 ° C under vacuum. For 15 minutes, the filters are prehybridized in a solution consisting of 50% formamide, 0.75 M NaCl, 0.075 M Na citrate, 0.1% SDS (sodium dodecyl sulfate), 1 mM EDTA (ethylenediaminetetraacetate), 0.02% Ficoll (polymer) (molecular weight = 400,000), 0.02% polyvinylpyrrolidone (molecular weight = 360,000) and 0.02% bovine serum albumin. The prehybridization takes place at 42 ° C.

Filtren placeras på dubbla filterpapper, som mättats med hybridiserings-' buffert (identisk med prehybridiseringslösningen frånsett att värmedenatu- 455 201 e rerat kaïvtymus DNA 75 pg/m1 tiiïsatts. Detta DNA har sonikerats för att ge DNA-fragment av medeïstorïek 2,5 x 105 daïton). Märkta DNA, s k prob- DNA, denatureras genom inkubering i 95°C under 10 min. Proben (50 P1) späds sedan i 42-gradig hybridiserings1ösning, och ca 100 ui probïösning appiiceras ti11 varje prov på fiïtren. Hybridisering får pågå under 1 tim vid 42°C. Slutïigen tvättas filtren två gånger vid 42°C (30 min/tvätt) i en buffert bestående av 0,75 M NaC1, 0,075 M Na-citrat samt 0,1 % SDS och två gånger i rumstemperatur (15 min/tvätt) med 0,3 M NaC1; 0,03 M Na- citrat. Sedan filtren Iufttorkats, räknas mängden märkt DNA som bundits ti11 provens DNA genom konventioneii kemiïuminiscensanaïys. Typiska re- suïtat ses i tabe11 1.The filters are placed on double filter papers, which are saturated with hybridization buffer (identical to the prehybridization solution except that heat-denatured calyx thymus DNA 75 pg / ml is added. This DNA has been sonicated to give DNA fragments of co-history 2.5 x 105 daïton). Labeled DNA, so-called probe DNA, is denatured by incubation at 95 ° C for 10 minutes. The probe (50 μl) is then diluted in 42-degree hybridization solution, and about 100 μl of probe solution is applied to each sample on the filter. Hybridization is allowed to proceed for 1 hour at 42 ° C. Finally, the filters are washed twice at 42 ° C (30 min / wash) in a buffer consisting of 0.75 M NaCl, 0.075 M Na-citrate and 0.1% SDS and twice at room temperature (15 min / wash) with 0 , 3 M NaCl; 0.03 M Na-citrate. After the filters have been air-dried, the amount of labeled DNA bound to the DNA of the samples by conventional chemistry analysis is counted. Typical results are shown in Table 11 1.

Exempel 2 Skydd vid inmärkning av det aktiva stäiiet för hybridisering 1 pg - fag M13 DNA innehåïiande 200 bp (baspar) specifikt probfragment biandas med 1 pg 200 bp renat probfragment i 0,1 M fosfatbuffert (pH 6,8).Example 2 Protection by labeling the active site for hybridization 1 pg - phage M13 DNA containing 200 bp (base pair) specific probe fragment is mixed with 1 pg 200 bp purified probe fragment in 0.1 M phosphate buffer (pH 6.8).

Lösningen upphettas tiil 9506 i 5 min och får sedan stå i rumstemperatur 10 tim. Proceduren fortsättes enïigt exempei 1. Typiska resu1tat kan ses i tabeii 2.The solution is heated to 9506 for 5 minutes and then allowed to stand at room temperature for 10 hours. The procedure is continued according to Example 1. Typical results can be seen in Table 2.

Tabe11 1 Bunden prob Isoiuminoï (mV) cpm (3H) Antaï bakt/m1 preiiminära värden (jämf) Y. pseudotubercuïosis pan 322 108 670 2400 106 30 323 Y. pseudotubercuïosis koneroii 108 25 168 Tamm 2 Enterotoxinproducerande e. C011' (Brac) 108 045 i 2163 Ej :Tec e. em konmm 108 ss 316 455 201 5 Jämföreïse har skett med märkning med radioaktiva isotoper (3H), och där- vid erhåiïna resuïtat framgår av tabeïierna 1 och 2. Därvid framgår att märkning med kemiïuminiscerande ämnen ger vä1 så goda resul tat, vilket visar att förfarandet enïigt uppfinningen utgör ett gott a1 ternativ tiH den hittiHs använda, radioaktiva metoden utan att vara behäftad med de oïägenheter som den radioaktiva märkningen medför.Tabe11 1 Bound probe Isoiuminoï (mV) cpm (3H) Antaï baked / m1 preliminary values (cf.) Y. pseudotubercuïosis pan 322 108 670 2400 106 30 323 Y. pseudotubercuïosis koneroii 108 25 168 Tamm 2 Enterotoxin-producing e 'C0. 045 i 2163 Ej: Tec e. Em konmm 108 ss 316 455 201 5 Comparison has been made with labeling with radioactive isotopes (3H), and the results obtained are shown in Tables 1 and 2. It is clear that labeling with cheminuminescent substances gives such good results, which shows that the process according to the invention constitutes a good alternative to the radioactive method used hitherto without being encumbered with the disadvantages which the radioactive labeling entails.

Claims (3)

455 201 Patentkrav:455 201 Patent claims: 1. Förfarande vid diagnostik med hjäïp av DNA-hybridiseringsteknik, exem- peivis för specifik påvisning av vävnader, ceïier, mikroorganismer e11er virus, k ä n n e t e c k n a t a v att ett artspecifikt fragment av deoxiribonukleinsyra (DNA) e11er ribonukïeinsyra (RNA) förses med en mar- kör och bringas att baspara e11er hybrídisera med ett homoiogt fragment hos det okända ämnet, varvid man som markör använder ett ämne som kan de- tekteras genom en kemiïuminiscensreaktion.Method in diagnostics using DNA hybridization techniques, for example for the specific detection of tissues, cells, microorganisms or viruses, characterized in that a species-specific fragment of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) is provided with a marker and is caused to base pair or hybridize with a homogeneous fragment of the unknown substance, using as a marker a substance that can be detected by a chemiluminescence reaction. 2. Förfarande enligt krav 1, k ä n n e t e c k n a t a v att man under inmärkningsförfarandet skyddar den artspecifika DNA-sekvensen resp RNA- sekvensen genom hybridisering med den homoioga sekvensen, varefter markö- ren koppias tili omgivande, icke-specifika de1ar av DNA e11er RNA-mo1eky- 1en och DNA-fragmentet ånyo denatureras, exempeïvis i a1ka1isk miïjö eiier genom upphettning, och sammanföres med det ämne som skaii diagnostiseras.Method according to claim 1, characterized in that during the labeling process the species-specific DNA sequence or the RNA sequence is protected by hybridization with the homogeneous sequence, after which the marker is copied to surrounding, non-specific parts of DNA or RNA molecules. The DNA fragment is again denatured, for example in an alkaline environment by heating, and combined with the substance to be diagnosed. 3. Mede1 för genomförande av förfarandet enïigt krav 1, k ä n n e - t e c k n a t a v att det utgöres av ett artspecifikt fragment av deoxiribonukieinsyra (DNA) eiler ribonukïeinsyra (RNA), vilket försetts med ett ämne som kan detekteras genom en kemiïuminiscensreaktion.3. A method of carrying out the method according to claim 1, characterized in that it consists of a species-specific fragment of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), which is provided with a substance which can be detected by a chemiluminescence reaction.
SE8200479A 1982-01-28 1982-01-28 Diagnostic technique for e.g. cell detection SE455201B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE8200479A SE455201B (en) 1982-01-28 1982-01-28 Diagnostic technique for e.g. cell detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8200479A SE455201B (en) 1982-01-28 1982-01-28 Diagnostic technique for e.g. cell detection

Publications (2)

Publication Number Publication Date
SE8200479L SE8200479L (en) 1983-07-29
SE455201B true SE455201B (en) 1988-06-27

Family

ID=20345857

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200479A SE455201B (en) 1982-01-28 1982-01-28 Diagnostic technique for e.g. cell detection

Country Status (1)

Country Link
SE (1) SE455201B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210449A2 (en) 1985-07-10 1987-02-04 Miles Inc. Prolonged chemiluminescence

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210449A2 (en) 1985-07-10 1987-02-04 Miles Inc. Prolonged chemiluminescence

Also Published As

Publication number Publication date
SE8200479L (en) 1983-07-29

Similar Documents

Publication Publication Date Title
US4994373A (en) Method and structures employing chemically-labelled polynucleotide probes
EP0420260B1 (en) Method and kit for detecting a target nucleic acid using a capture probe bound to a polystyrene support via an intermediary protein.
US5856092A (en) Detection of a nucleic acid sequence or a change therein
JP2618381B2 (en) Methods and kits for performing nucleic acid hybridization assays
DE69114023T2 (en) Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and isolation procedures.
EP0457824B2 (en) Detection of a nucleic acid sequence or a change therein
US5989817A (en) Target nucleic acid and capture method
US4751177A (en) Methods and kits for performing nucleic acid hybridization assays
JP3436538B2 (en) Improved strand displacement assays and conjugates useful therein
US6060242A (en) PNA diagnostic methods
US5273882A (en) Method and kit for performing nucleic acid hybridization assays
US5641630A (en) Method and kit for performing nucleic acid hybridization assays
JPH07246100A (en) Nucleic acid detection method
JPH02303489A (en) Amplification of nucleic acid sequence using random sequence oligonucleotide as primer
JPS60100056A (en) Method for detecting bacteria using nucleic acid hybridization method
DE3888653T2 (en) Method and test kit for the detection of a nucleic acid sequence.
JPH03103199A (en) Nucleic acid detection method
EP0405913A2 (en) Hydrophobic nucleic acid probe
JPH08501220A (en) Isolated nucleotide sequence for identification of Neisseria gonorrhoeae
AU607393B2 (en) Shaped articles, which are provided with coatings, for the binding of substances having a bioaffinity, a process for their preparation, and their use
DE102009032502A1 (en) Detection of antigens
SE455201B (en) Diagnostic technique for e.g. cell detection
JP3607327B2 (en) Rapid detection of single microbial cells
EP0797778B1 (en) A method for preparing non-proteinaceous strongly negatively charged macrobiomolecules, which are linked to plastic
JP2651317B2 (en) Nucleic acid detection method

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8200479-7

Effective date: 19920806

Format of ref document f/p: F